8-K - Syndax Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Charter Amendment

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On December 18, 2025, the Board of Directors of Syndax Pharmaceuticals Inc. (the “ Com

Charter Amendment

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 3.1 Amended and Restated Bylaws of Syndax Pharmaceuticals Inc. dated December 18, 2025 1

Exhibits Only

Exhibits (2)

3.1

EX-3.1

8-K